Potent and speci?c genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature, vol.391, pp.806-811, 1998. ,
Lipid-based nanoparticles in the systemic delivery of siRNA, Nanomedicine, issue.9, pp.105-120, 2014. ,
Interfering cancer with polymeric siRNA nanomedicines, J. Biomed. Nanotechnol, vol.10, pp.50-66, 2014. ,
The Role of the Helper Lipid on the DNA Transfection Efficiency of Lipopolyplex Formulations, Sci. Rep, p.7107, 2014. ,
Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications, Biochim. Biophys. Acta, vol.1113, pp.201-227, 1992. ,
A review of the current status of siRNA nanomedicines in the treatment of cancer, Biomaterials, vol.34, pp.6429-6443, 2013. ,
Non-viral nanosystems for systemic siRNA delivery, Pharmacol. Res, vol.62, pp.100-114, 2010. ,
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer, Biomaterials, vol.29, pp.3477-3496, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00353462
Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma, Biotechnol. J, vol.9, pp.1389-1401, 2014. ,
siRNA LNCs-a novel platform of lipid nanocapsules for systemic siRNA administration, Eur. J. Pharm. Biopharm, vol.81, pp.448-452, 2012. ,
EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro, Int. J. Pharm, vol.454, pp.748-755, 2013. ,
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, pp.321-329, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00491402
In vivo imaging of DNA lipid nanocapsules a?er systemic administration in a melanoma mouse model, Int. J. Pharm, vol.423, pp.108-115, 2012. ,
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, vol.65, pp.271-284, 2000. ,
Folate-equipped pegylated archaeal lipid derivatives: synthesis and transfection properties, Chemistry, vol.14, pp.8330-8340, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00403237
New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery, Recent Pat, Drug Deliv. Formulation, vol.3, pp.206-220, 2009. ,
Preparation and Characterization of Stealth Archaeosomes Based on a Synthetic PEGylated Archaeal Tetraether Lipid, J. Drug Delivery, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00753450
Stimuli-sensitive nanopreparations for combination cancer therapy, J. Control. Release, vol.190, pp.352-370, 2014. ,
The archaeal "7 kDa DNA-binding" proteins: extended characterization of an old gi?ed family, Sci. Rep, vol.6, p.37274, 2016. ,
Tolerance of the archaeal Sac7d scaffold protein to alternative library designs: characterization of anti-immunoglobulin G Affitins, Protein Eng. Des. Sel, vol.26, pp.267-275, 2013. ,
Potent and speci?c inhibition of glycosidases by small arti?cial binding proteins (affitins), PLoS One, vol.9, p.97438, 2014. ,
Remodeling a DNA-binding protein as a speci?c in vivo inhibitor of bacterial secretin PulD, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.17983-17988, 2007. ,
Switching an anti-IgG binding site between archaeal extremophilic proteins results in Affitins with enhanced pH stability, J. Biotechnol, pp.123-129, 2014. ,
Affitins as robust tailored reagents for affinity chromatography puri?cation of antibodies and nonimmunoglobulin proteins, J. Chromatogr. A, pp.44-51, 1441. ,
Affitins for protein puri?cation by affinity magnetic ?shing, J. Chromatogr. A, vol.1457, pp.50-58, 2016. ,
A novel, smaller scaffold for Affitins: Showcase with binders speci?c for EpCAM, Biotechnol. Bioeng, vol.115, pp.290-299, 2018. ,
Affinity transfer to the archaeal extremophilic Sac7d protein by insertion of a CDR, Protein Eng. Des. Sel, vol.27, pp.431-438, 2014. ,
Whole-bacterium ribosome display selection for isolation of highly speci?c anti-Staphyloccocus aureus Affitins for detection-and capture-based biomedical applications, Biotechnol. Bioeng, vol.116, pp.1844-1855, 2019. ,
Towards combinatorial targeted therapy in melanoma: from pre-clinical evidence to clinical application (review), Int. J. Oncol, vol.45, pp.929-949, 2014. ,
Anti-angiogenic inhibition of tumor growth by systemic delivery of, J. Control. Release, vol.114, pp.381-388, 2006. ,
Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133, Int. J. Pharm, vol.423, pp.93-101, 2012. ,
A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharm. Res, vol.19, pp.875-880, 2002. ,
Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel, Eur. J. Pharm. Biopharm, vol.73, pp.239-246, 2009. ,
Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells, Eur. J. Pharm. Sci, vol.40, pp.422-429, 2010. ,
The encapsulation of DNA molecules within biomimetic lipid nanocapsules, Biomaterials, vol.30, pp.3197-3204, 2009. ,
PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy, Biomaterials, vol.35, pp.7978-7991, 2014. ,
The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability, Biomaterials, vol.31, pp.7542-7554, 2010. ,
Formation and intracellular trafficking of lipoplexes and polyplexes, Mol. Ther, vol.11, pp.336-347, 2005. ,
Enhanced bactericidal potency of nanoliposomes by modi?cation of the fusion activity between liposomes and bacterium, Int. J. Nanomed, vol.8, pp.2351-2360, 2013. ,
Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring, J. Control. Release, vol.188, pp.1-8, 2014. ,
In?uence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles, Int. J. Nanomed, vol.7, pp.5889-5900, 2012. ,
Endocytosis of PEGylated nanoparticles accompanied by structural and free energy changes of the gra?ed polyethylene glycol, Biomaterials, vol.35, pp.8467-8478, 2014. ,
The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles, Nat. Nanotechnol, vol.6, pp.385-391, 2011. ,
A comprehensive study of iRGD-modi?ed liposomes with improved chemotherapeutic efficacy on B16 melanoma, Drug Deliv, vol.22, pp.10-20, 2015. ,
The smart targeting of nanoparticles, Curr. Pharm. Des, vol.19, pp.6315-6329, 2013. ,
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting, Nanomedicine, vol.5, pp.1415-1433, 2010. ,
Acidic extracellular microenvironment and cancer, Cancer Cell Int, p.89, 2013. ,
Highly efficient siRNA delivery from coreshell mesoporous silica nanoparticles with multifunctional polymer caps, Nanoscale, vol.7, p.4007, 2016. ,
Enhanced Gene Delivery and siRNA Silencing by Gold Nanoparticles Coated with Charge-Reversal Polyelectrolyte, ACS Nano, vol.4, pp.5505-5511, 2010. ,
Carbon Nanotubes: Solution for the Therapeutic Delivery of siRNA?, Materials, vol.5, pp.278-301, 2012. ,
Polymeric nanoparticles for siRNA delivery: production and applications, Int. J. Pharm, vol.525, pp.313-333, 2017. ,
Lipid nanoparticles for targeted siRNA delivery -going from bench to bedside, Int. J. Pharm, vol.11, pp.3077-3086, 2016. ,
A new tool to ensure the ?uorescent dye labeling stability of nanocarriers: a real challenge for ?uorescence imaging, J. Control. Release, vol.170, pp.334-342, 2013. ,
Enhanced cellular uptake of albuminbased lyophilisomes when functionalized with cellpenetrating peptide TAT in HeLa cells, PloS one, vol.9, p.110813, 2014. ,
Trypan Blue staining method for quenching the auto?uorescence of RPE cells for improving protein expression analysis, Exp. Eye Res, vol.93, pp.956-962, 2011. ,